[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"biomarker:protein-smoothened":3},{"name":4,"total":5,"recruiting":5,"trials":6},"Protein Smoothened",1,[7],{"nct_id":8,"title":9,"phases":10,"status":12,"updated_at":13,"content_modified":14},"NCT02523014","Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas",[11],"Phase 2","RECRUITING","2026-08-26T02:16:38.897933Z","2026-05-05T02:43:27.482521Z"]